Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Nancy Gorban-Brennan"'
Publikováno v:
Nephrology. 10:442-445
SUMMARY: Objective: C-reactive protein (CRP) levels increase during peritonitis. Little is known about the extent and duration of CRP elevation. Patients and Methods: Patients on continuous peritoneal dialysis (CPD) therapy had a baseline CRP value a
Publikováno v:
Seminars in Dialysis. 16:428-437
The percentage of end-stage renal disease (ESRD) patients in the United States maintained on continuous peritoneal dialysis (CPD) therapy is decreasing. Complications from CPD therapy, including peritonitis, may be the reason for the decline. Improve
Autor:
Nancy Gorban-Brennan, Fredric O Finkelstein, Diane Wuerth, Alan S. Kliger, Suzanne Watnick, Laura Troidle
Publikováno v:
American Journal of Kidney Diseases. 42:350-354
Depression is the most common psychological disorder among patients with end-stage renal disease and has been associated with mortality in patients maintained on hemodialysis therapy. Peritonitis is the leading cause of technique failure among long-t
Autor:
Nancy Gorban-Brennan, Laura Troidle, Alan S. Kliger, Fredric O. Finkelstein, Pradeep V. Kadambi
Publikováno v:
Seminars in Dialysis. 15:430-433
Few elderly patients with end-stage renal disease (ESRD) are treated with peritoneal dialysis (PD). Among dialysis patients >or=65 years of age reported by the U.S. Renal Data System (USRDS), the percentage treated with chronic peritoneal dialysis (C
Autor:
Nancy Gorban-Brennan, Laura Troidle, James Jekel, Frank J. Bia, Emily S. Finkelstein, Fredric O. Finkelstein
Publikováno v:
American Journal of Kidney Diseases. 39:1278-1286
The causes of peritonitis in patients with end-stage renal disease maintained on long-term peritoneal dialysis (PD) are unclear. One possible explanation for peritonitis, particularly in patients with multiple episodes of infection, is the release of
Publikováno v:
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis. 29
Patients with end-stage renal disease treated with peritoneal dialysis (PD) are often put on standard one size fits all" regimens, despite having varying degrees of residual renal function (RRF). The present study reports our experience with initiati
Publikováno v:
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 19:376-379
Objective Long-term chronic peritoneal dialysis (CPD) therapy has been associated with alterations in peritoneal membrane structure and peritoneal macrophage function. We thus reviewed our experience with the development of peritonitis among patients
Autor:
Ana E, Taveras, Amenuve M, Bekui, Nancy, Gorban-Brennan, Radu, Raducu, Fredric O, Finkelstein
Publikováno v:
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis. 28
The role of peritoneal dialysis (PD) in the treatment of end-stage renal disease in elderly patients remains unclear. In the United States, PD is used only to a limited extent in that population. There are concerns about technique failure, including
Autor:
Margaret Fikrig, Frederic O. Finkelstein, Alan S. Kliger, Sue J. Goldie, Eric Brown, Laura Troidle, Nancy Gorban-Brennan
Publikováno v:
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 16:505-510
ObjectiveTo describe our experience with nosocomial continuous peritoneal dialysis (CPD)-associated peritonitis focusing on the incidence, possible risk factors, spectrum of organisms, and outcome.DesignRetrospective review of the medical records of
Autor:
Edward F. Vonesh, Laura Kiernan, Peter H. Juergensen, Nancy Gorban-Brennan, David Tesin, Alan S. Kliger, Frederic O. Finkelstein
Publikováno v:
Journal of the American Society of Nephrology. 5:1835-1838
Despite several modifications of the continuous ambulatory peritoneal dialysis (CAPD) technique over the last decade, peritonitis remains a major source of morbidity and is the leading cause of dropout for patients maintained on CAPD therapy. Recentl